Clinical trials: Patients With Newly Diagnosed Active NISU
Patients With Newly Diagnosed Active NISU
A Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU)
Uveitis is characterized by inflammation of the uvea, which is the middle portion of the eye. The greatest challenge for the treatment of uveitis is patients who have inflammation involving the posterior segment, either primarily…
- Trial name
- USTEKINISU (NCT03847272)
- Testing
- prednisone and ustekinumab treatment, Ophthalmologic examination, Questionnaires
- Where
- 2 sites in France
- Volunteers
- 15 people
- Sponsor
- Centre Hospitalier Universitaire Dijon